Wednesday, July 8, 2026

Patent intelligence · US

US 9932587

Methods of identifying and treating poor prognosis cancers

granted A61KA61K31/00A61K31/337A61K31/704
Status granted
Linked drugs 3
Pipeline programs 1
Years to expiry 12
Applicant portfolio 163
Patent details — US 9932587
Jurisdiction
US
Status
granted
Grant date
Apr 3, 2018
Expiration
Mar 29, 2038
Claims
18
CPC classes
A61K, A61K31/00, A61K31/337, A61K31/704
View on Google Patents ↗

Quick answer

US 9932587 (Methods of identifying and treating poor prognosis cancers) is held by THE TRUSTEES OF PRINCETON UNIVERSITY. Status: granted. Granted Apr 3, 2018. Expires Mar 29, 2038 (12 years remaining) — relevant for patent-cliff and LOE planning.

Key facts

Grant date
Expiration
Claims
18
CPC classes
A61K, A61K31/00, A61K31/337, A61K31/704, A61K31/7105, A61K31/713

More from THE TRUSTEES OF PRINCETON UNIVERSITY

Related pharmaceutical patents in our USPTO index.

  1. US 12419831

    Hydrocortisone oral liquid formulations

    Eton Pharmaceuticals, Inc. · Expires Sep 18, 2045

    granted
  2. US 12396974

    Ketone ester as a therapeutic treatment of Covid-19 and related viral infections

    KetoneAid · Expires Aug 21, 2045

    granted
  3. US 12357582

    Hydrophobic ion pairing and flash nanoprecipitation for formation of controlled-release nanocarrier formulations

    THE TRUSTEES OF PRINCETON UNIVERSITY · Expires Jul 10, 2045

    granted
  4. US 12343324

    Dihydromyricetin hot melt extrusion formulations and methods for forming them

    THE TRUSTEES OF PRINCETON UNIVERSITY · Expires Jun 26, 2045

    granted
  5. US 12329816

    Immunotherapy with metabolic enzyme expression

    THE TRUSTEES OF PRINCETON UNIVERSITY · Expires Jun 12, 2045

    granted
  6. US 12209256

    System for protein inactivation and recombinant phages for targeted bacterial killing, infection, biodetection, and as a means of protein extraction

    THE TRUSTEES OF PRINCETON UNIVERSITY · Expires Jan 23, 2045

    granted
  7. US 12195768

    System and method for modulating stress granule assembly

    THE TRUSTEES OF PRINCETON UNIVERSITY · Expires Jan 9, 2045

    granted
  8. US 12186436

    Triblock copolymer stabilizers for the formation of nanoparticles encapsulating soluble biologics, therapeutics, and imaging agents

    THE TRUSTEES OF PRINCETON UNIVERSITY · Expires Jan 2, 2045

    granted

Frequently asked questions

What is US patent 9932587?

US 9932587 (Methods of identifying and treating poor prognosis cancers) is held by THE TRUSTEES OF PRINCETON UNIVERSITY. Status: granted. Granted Apr 3, 2018. Expires Mar 29, 2038 (12 years remaining) — relevant for patent-cliff and LOE planning.

Who owns US 9932587?

THE TRUSTEES OF PRINCETON UNIVERSITY is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 163 pharmaceutical patents for this assignee.

When does US 9932587 expire?

Our index shows an expiration date of Mar 29, 2038 (12 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.